Instil Bio eyes key NSCLC catalyst with Phase 2 China data in 2H 2025 and a distinct U.S. strategy. Learn why AXN-2510 stands ...

Detailed price information for Compass Therapeutics Inc (CMPX-Q) from The Globe and Mail including charting and trades.

(NASDAQ: OABI, “OmniAb”) for the development of a novel bispecific antibody drug conjugate ... changes to the proposed structure of the Business Combination that may be required or appropriate ...

Writingstar Investment Guild today announced the official launch of its multilingual learning initiative, unveiling newly developed course modules in German, French, and Japanese. This strategic move, ...

Under the terms of the agreement, VERAXA will initiate a novel bispecific antibody drug conjugate ... changes to the proposed structure of the Business Combination that may be required or ...

Analysts have set 12-month price targets for Regeneron Pharmaceuticals, revealing an average target of $808.67, a high ...